Related Experiment Videos
Protease inhibitors reduce mitogen induced lymphocyte stimulation
Immunology
|April 1, 1979
Summary
Protease inhibitors soybean inhibitor and Trasylol reduced lymphocyte activation by mitogens. Other inhibitors had minimal impact, suggesting specific protease roles in lymphocyte responses.
Area of Science:
- Immunology
- Biochemistry
Background:
- Lymphocyte activation is a complex process.
- The role of proteolytic enzymes in lymphocyte activation is not fully understood.
Purpose of the Study:
- To investigate the potential role of proteolytic events in lymphocyte activation.
- To determine the effect of various protease inhibitors on lymphocyte proliferation.
Main Methods:
- Mouse spleen cells were cultured in serum-free conditions.
- Cells were stimulated with mitogens: phytohemagglutinin (PHA), concanavalin A (ConA), lipopolysaccharide (LPS), and dextran sulfate.
- The impact of protease inhibitors on [3H]-thymidine incorporation was measured.
Main Results:
- Soybean inhibitor and Trasylol significantly inhibited lymphocyte proliferation in response to all tested mitogens.
- Antipain, leupeptin, ovomucoid, alpha-1 trypsin, and alpha-2 macroglobulin showed little to no inhibitory effect.
- Tosyl-lysine chloromethylketone's inhibition was reversed by reduced glutathione, suggesting an effect on cellular glutathione levels, not proteases.
Conclusions:
- Specific protease inhibitors, soybean inhibitor and Trasylol, can modulate lymphocyte activation.
- The findings suggest that certain proteolytic pathways may be involved in mitogen-induced lymphocyte proliferation.
- Further research is needed to elucidate the precise mechanisms and specific proteases involved.